1. Stereotactic Ablative Radiotherapy (SABR) in Patients with Medically Inoperable Peripheral Early Stage Lung Cancer: Outcomes for the First UK SABR Cohort. Issue 1 (January 2016) Authors: Murray, L.; Ramasamy, S.; Lilley, J.; Snee, M.; Clarke, K.; Musunuru, H.B.; Needham, A.; Turner, R.; Sangha, V.; Flatley, M.; Franks, K. Journal: Clinical oncology Issue: Volume 28:Issue 1(2016) Page Start: 4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Is Substantial Lymphovascular Space Invasion Prognostic for Clinical Outcomes in Type II Endometrial Cancer?. Issue 7 (July 2022) Authors: Jaishankar, S.; Pifer, P.M.; Bhargava, R.; Keller, A.; Musunuru, H.B.; Patel, A.K.; Sukumvanich, P.; Boisen, M.; Berger, J.L.; Taylor, S.; Courtney-Brooks, M.; Olawaiye, A.; Lesnock, J.; Edwards, R.; Vargo, J.A.; Beriwal, S. Journal: Clinical oncology Issue: Volume 34:Issue 7(2022) Page Start: 452 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PD-0913 Is substantial LVSI prognostic in patients with pathological lymph node-negative endometrial cancer?. (May 2022) Authors: Pifer, P.; Jaishankar, S.; Bhargava, R.; Keller, A.; Musunuru, H.B.; Cohen, M.; Sukumvanich, P.; Courtney-Brooks, M.; Boisen, M.; Berger, J.; Taylor, S.; Olawaiye, A.; Lesnock, J.; Edwards, R.; Vargo, J.A.; Beriwal, S. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S809 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. EP-1322: 3D-CRT, VMAT and dose escalation for pancreatic radiotherapy planning. (April 2015) Authors: Junni, P.; Murray, L.; Musunuru, H.B.; Lilley, J.; Wilson, S.; Crellin, A.; Sebag-Montefiore, D.; Radhakrishna, G. Journal: Radiotherapy and oncology Issue: Volume 115(2015)Supplement 1 Page Start: S713 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. EP-1341: Pelvic SABR with HDR boost in intermediate and high risk prostate cancer (spare): early results. (May 2017) Authors: Musunuru, H.B.; Deabreu, A.; Davidson, M.; Ravi, A.; Hlou, J.; Ho, L.; Cheung, P.; Vesprini, D.; Liu, S.; Chu, W.; Chung, H.; Zhang, L.; Loblaw, A. Journal: Radiotherapy and oncology Issue: Volume 123:(2017:May)Supplement 1 Page Start: S719 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Stereotactic Body Radiotherapy versus Low Dose Rate Brachytherapy for Localised Prostate Cancer: a Cost–Utility Analysis. Issue 11 (November 2017) Authors: Helou, J.; Torres, S.; Musunuru, H.B.; Raphael, J.; Cheung, P.; Vesprini, D.; Chung, H.T.; D'Alimonte, L.; Krahn, M.; Morton, G.; Loblaw, A. Journal: Clinical oncology Issue: Volume 29:Issue 11(2017) Page Start: 718 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗